Also trades as: 1466.HK (HKSE) · $vol 0M
MNNGF OTC
Baijin Life Science Holdings Limited
1W: +0.0%
1M: +50.0%
3M: +100.0%
YTD: +150.0%
1Y: +87.5%
3Y: +150.0%
5Y: +1150.0%
$0.15
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$7M
+76.0% ▲
Capital Expenditures
$15M
-529.9% ▼
5Y CAGR: +261.3%
Free Cash Flow
-$23M
+31.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$5M
-147.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$15M | $9M | -$9M | -$1M | -$38M |
| Depreciation & Amort. | $1M | $1M | $2M | $7M | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $4M | -$1M | $15M | -$34M | $23M |
| Other Non-Cash Items | $11M | -$30M | -$15M | -$2M | $7M |
| Operating Cash Flow | $1M | -$22M | -$6M | -$31M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | -$46K | -$26K | -$179K | -$2M | -$15M |
| Acquisitions (Net) | -$19K | $0 | $4M | $0 | -$1M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $5K | $35M | $1M | $2M | $648K |
| Investing Cash Flow | -$60K | $35M | $5M | -$846K | -$16M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$679K | -$1M | $2M | $3M | $560K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$6M | -$28M | -$1M | -$2M | -$6M |
| Financing Cash Flow | -$2M | $4M | $819K | $41M | $18M |
| Net Change in Cash | -$839K | $18M | -$3M | $10M | -$5M |
| Cash End of Period | $24M | $41M | $38M | $48M | $43M |
| Free Cash Flow | $1M | -$22M | -$7M | -$33M | -$23M |